Dental curable composition, and method for producing same

Patent metadata

Field	Value
Publication number	US-9427381-B2
Application number	US-201314431939-A
Country	US
Kind code	B2
Filing date	Sep 26, 2013
Priority date	Sep 28, 2012
Publication date	Aug 30, 2016
Grant date	Aug 30, 2016

Abstract

A dental curable composition containing fluoroaluminosilicate glass particles (A), basic calcium phosphate particles (B1), acidic calcium phosphate particles (B2), a polyalkenic acid (C), tartaric acid (D), and water (E), wherein the dental curable composition contains 70 to 99 parts by weight of (A), 1 to 30 parts by weight in total of (B1) and (B2), 10 to 40 parts by weight of (C), 0.3 to 10 parts by weight of (D), and 10 to 90 parts by weight of (E) each relative to 100 parts by weight in total of (A), (B1), and (B2), and a Ca/P ratio of a sum of (B1) and (B2) is from 1.10 to 1.95. Accordingly, provided is a dental curable composition that is high in mechanical strength, particularly compressive strength, and excellent in remineralization capability.

First claim

The invention claimed is:

1. A dental curable composition comprising:
fluoroaluminosilicate glass particles (A), basic calcium phosphate particles (B1), acidic calcium phosphate particles (B2), a polyalkenic acid (C), tartaric acid (D), and water (E), wherein the tartaric acid (D) is L-tartaric acid,
wherein
the dental curable composition comprises from 70 to 99 parts by weight of the fluoroaluminosilicate glass particles (A), from 1 to 30 parts by weight in total of the basic calcium phosphate particles (B1) and the acidic calcium phosphate particles (B2), from 10 to 40 parts by weight of the polyalkenic acid (C), from 0.3 to 10 parts by weight of the tartaric acid (D), and from 10 to 90 parts by weight of the water (E) each relative to 100 parts by weight in total of the fluoroaluminosilicate glass particles (A), the basic calcium phosphate particles (B1), and the acidic calcium phosphate particles (B2), and a Ca/P ratio of a sum of the basic calcium phosphate particles (B1) and the acidic calcium phosphate particles (B2) is from 1.10 to 1.95.

2. The dental curable composition according to claim 1 , wherein the basic calcium phosphate particles (B1) are at least one member selected from the group consisting of particles of tetracalcium phosphate [Ca 4 (PO 4 ) 2 O] and particles of octacalcium phosphate pentahydrate [Ca 8 H 2 (PO 4 ) 6 .5H 2 O], and the acidic calcium phosphate particles (B2) are at least one member selected from the group consisting of particles of anhydrous calcium monohydrogen phosphate [CaHPO 4 ], particles of tricalcium phosphate [Ca 3 (PO 4 ) 2 ], particles of anhydrous calcium dihydrogen phosphate [Ca(H 2 PO 4 ) 2 ], particles of amorphous calcium phosphate [Ca 3 (PO 4 ) 2 .xH 2 O], particles of acidic calcium pyrophosphate [CaH 2 P 2 O 7 ], particles of calcium monohydrogen phosphate dihydrate [CaHPO 4 .2H 2 O], and particles of calcium dihydrogen phosphate monohydrate [Ca(H 2 PO 4 ) 2 .H 2 O].

3. The dental curable composition according to claim 1 , wherein the dental curable composition is a glass ionomer cement.

4. A method for producing a dental curable composition according to claim 1 , the method comprising mixing a powder agent (X) comprising at least fluoroaluminosilicate glass particles (A), basic calcium phosphate particles (B1), and acidic calcium phosphate particles (B2), with a liquid agent (Y) comprising at least a polyalkenic acid (C), tartaric acid (D), and water (E), wherein
a weight ratio (X/Y) of the powder agent (X) to the liquid agent (Y) is from 1.0 to 5.0.

5. The method for producing a dental curable composition according to claim 4 , wherein the fluoroaluminosilicate glass particles (A) have an average particle size of from 0.3 to 35 μm, the basic calcium phosphate particles (B1) have an average particle size of from 3 to 35 μm, and the acidic calcium phosphate particles (B2) have an average particle size of from 0.3 to 10 μm.

6. A dental curable composition kit comprising:
a powder agent (X) comprising at least fluoroaluminosilicate glass particles (A), basic calcium phosphate particles (B1), and acidic calcium phosphate particles (B2), and
a liquid agent (Y) comprising at least a polyalkenic acid (C), tartaric acid (D), and water (E), wherein the tartaric acid (D) is L-tartaric acid, and
wherein the powder agent (X) and the liquid agent (Y) are mixed in a weight ratio (X/Y) within a range of from 1.0 to 5.0.

7. The dental curable composition kit according to claim 6 , wherein the fluoroaluminosilicate glass particles (A) have an average particle size of from 0.3 to 35 μm, the basic calcium phosphate particles (B1) have an average particle size of from 3 to 35 μm, and the acidic calcium phosphate particles (B2) have an average particle size of from 0.3 to 10 μm.

8. The dental curable composition according to claim 1 , comprising from 0.3 to 7 parts by weight of the tartaric acid (D).

9. The dental curable composition according to claim 1 , comprising from 0.3 to 5 parts by weight of the tartaric acid (D).

10. The method for producing a dental curable composition according to claim 1 , wherein the fluoroaluminosilicate glass particles (A) have an average particle size of from 0.5 to 30 μm.

11. The method for producing a dental curable composition according to claim 1 , comprising from 2 to 20 parts by weight in total of the basic calcium phosphate particles (B1) and the acidic calcium phosphate particles (B2).

12. The method for producing a dental curable composition according to claim 1 , comprising from 3 to 10 parts by weight in total of the basic calcium phosphate particles (B1) and the acidic calcium phosphate particles (B2).

13. The method for producing a dental curable composition according to claim 1 , wherein the basic calcium phosphate particles (B1) have an average particle size of from 5 to 30 μm.

14. The method for producing a dental curable composition according to claim 1 , wherein the basic calcium phosphate particles (B1) have an average particle size of from 5 to 30 μm.

15. The method for producing a dental curable composition according to claim 1 , wherein the acidic calcium phosphate particles (B2) have an average particle size of from 0.5 to 5 μm.

16. The method for producing a dental curable composition according to claim 1 , wherein the Ca/P ratio of a sum of the basic calcium phosphate particles (B1) and the acidic calcium phosphate particles (B2) is from 1.1 to 1.7.

17. The method for producing a dental curable composition according to claim 1 , comprising from 10 to 30 parts by weight of the polyalkenic acid (C).

18. The method for producing a dental curable composition according to claim 1 , wherein the polyalkenic acid (C) is at least one polymer selected from the group consisting of a homopolymer and copolymer of acrylic acid, methacrylic acid, 2-chloroacrylic acid, 2-cyanoacrylic acid, aconitic acid, mesaconic acid, maleic acid, itaconic acid, fumaric acid, glutaconic acid, citraconic acid, and utraconic acid.

19. The method for producing a dental curable composition according to claim 1 , wherein the polyalkenic acid (C) is a polymer having a weight average molecular weight of from 5,000 to 50,000 and contains no polymerizable ethylenically unsaturated double bonds.

20. The method for producing a dental curable composition according to claim 1 , further comprising at least component selected from the group consisting of a filler and a pigment.

Assignees

• Kuraray Noritake Dental Inc

Inventors

• Ishihara Shumei
• Hatanaka Kenji

Classifications

• A61K6/76

  comprising silicon-containing compounds · CPC title

• A61K6/74 Primary

  comprising phosphorus-containing compounds · CPC title

• A61K6/0088

  Human Necessities · mapped topic

• A61K6/0082 Primary

  Human Necessities · mapped topic